Cargando…

Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis

INTRODUCTION: The ever-increasing global hepatitis C infection is fueling the burden of diabetes mellitus, which exaggerates various complications and may be a cause of death for millions. Several studies have reported that hepatitis C virus infection is an important risk factor for the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambachew, Sintayehu, Eshetie, Setegn, Geremew, Demeke, Endalamaw, Aklilu, Melku, Mulugeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388482/
https://www.ncbi.nlm.nih.gov/pubmed/30803444
http://dx.doi.org/10.1186/s13643-019-0976-x
_version_ 1783397773327990784
author Ambachew, Sintayehu
Eshetie, Setegn
Geremew, Demeke
Endalamaw, Aklilu
Melku, Mulugeta
author_facet Ambachew, Sintayehu
Eshetie, Setegn
Geremew, Demeke
Endalamaw, Aklilu
Melku, Mulugeta
author_sort Ambachew, Sintayehu
collection PubMed
description INTRODUCTION: The ever-increasing global hepatitis C infection is fueling the burden of diabetes mellitus, which exaggerates various complications and may be a cause of death for millions. Several studies have reported that hepatitis C virus infection is an important risk factor for the development of diabetes mellitus. However, the results of fragmented studies reported variable and inconsistent findings on the prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients. Therefore, this protocol for meta-analysis will determine the overall pooled prevalence of type 2 diabetes mellitus in patients infected with hepatitis C virus. METHODS AND ANALYSIS: This systematic review and meta-analysis will include original articles of cohort and cross-sectional studies published in English. A systematic search will be performed in PubMed, Science Direct, Scopus, and Google Scholar. A fixed/random-effects meta-analysis model will be used to estimate the global pooled prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients. Sensitivity analysis will be conducted to check the stability of the summary estimate. Heterogeneity will be assessed using the I(2) statistic. Subgroup analysis will also be conducted based on geographical region. Funnel plots and Egger’s test and Begg’s test will be used to assess for publication bias. ETHICS AND DISSEMINATION: The review is based on published data; therefore, ethical approval is not required. The systematic review and meta-analysis will summarize the existing data on the prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients at the global level. This provides the empirical evidence necessary for researchers, policymakers, and public health stakeholders to derive health-promoting policies, allocate resources, and set priorities for monitoring future trends. The final result will be presented at annual scientific meetings, conferences, and seminars. Moreover, it will also be published in a peer-reviewed reputable journal. We also plan to review every 5 years to provide updated information. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018083409 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13643-019-0976-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6388482
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63884822019-03-19 Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis Ambachew, Sintayehu Eshetie, Setegn Geremew, Demeke Endalamaw, Aklilu Melku, Mulugeta Syst Rev Protocol INTRODUCTION: The ever-increasing global hepatitis C infection is fueling the burden of diabetes mellitus, which exaggerates various complications and may be a cause of death for millions. Several studies have reported that hepatitis C virus infection is an important risk factor for the development of diabetes mellitus. However, the results of fragmented studies reported variable and inconsistent findings on the prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients. Therefore, this protocol for meta-analysis will determine the overall pooled prevalence of type 2 diabetes mellitus in patients infected with hepatitis C virus. METHODS AND ANALYSIS: This systematic review and meta-analysis will include original articles of cohort and cross-sectional studies published in English. A systematic search will be performed in PubMed, Science Direct, Scopus, and Google Scholar. A fixed/random-effects meta-analysis model will be used to estimate the global pooled prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients. Sensitivity analysis will be conducted to check the stability of the summary estimate. Heterogeneity will be assessed using the I(2) statistic. Subgroup analysis will also be conducted based on geographical region. Funnel plots and Egger’s test and Begg’s test will be used to assess for publication bias. ETHICS AND DISSEMINATION: The review is based on published data; therefore, ethical approval is not required. The systematic review and meta-analysis will summarize the existing data on the prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients at the global level. This provides the empirical evidence necessary for researchers, policymakers, and public health stakeholders to derive health-promoting policies, allocate resources, and set priorities for monitoring future trends. The final result will be presented at annual scientific meetings, conferences, and seminars. Moreover, it will also be published in a peer-reviewed reputable journal. We also plan to review every 5 years to provide updated information. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018083409 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13643-019-0976-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-25 /pmc/articles/PMC6388482/ /pubmed/30803444 http://dx.doi.org/10.1186/s13643-019-0976-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Protocol
Ambachew, Sintayehu
Eshetie, Setegn
Geremew, Demeke
Endalamaw, Aklilu
Melku, Mulugeta
Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis
title Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis
title_full Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis
title_fullStr Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis
title_full_unstemmed Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis
title_short Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis
title_sort prevalence of type 2 diabetes mellitus among hepatitis c virus-infected patients: a protocol for systematic review and meta-analysis
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388482/
https://www.ncbi.nlm.nih.gov/pubmed/30803444
http://dx.doi.org/10.1186/s13643-019-0976-x
work_keys_str_mv AT ambachewsintayehu prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis
AT eshetiesetegn prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis
AT geremewdemeke prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis
AT endalamawaklilu prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis
AT melkumulugeta prevalenceoftype2diabetesmellitusamonghepatitiscvirusinfectedpatientsaprotocolforsystematicreviewandmetaanalysis